Volanesorsen (Waylivra) is a prescription medication indicated for the treatment of familial chylomicronemia syndrome (FCS) in adult patients, particularly those who have not responded adequately to diet and other triglyceride-lowering therapies and are at high risk of pancreatitis.

What are the Purchase Channels for Volanesorsen (Waylivra)?

Overseas Purchase

Patients may consult and purchase volanesorsen at hospital pharmacies or legitimate drugstores in countries/regions where the medication is marketed.

Since drug prices may be affected by regional differences, exchange rate fluctuations, and other factors, patients should make a budget and plan in advance before purchasing.

Purchase Through Medical Service Institutions

Patients may consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.

These institutions usually provide legal import channels and offer professional consultation and guidance.

Precautions for Purchasing Volanesorsen (Waylivra)

Strictly Comply with Prescriptions and Medical Regulations

Volanesorsen is a restricted prescription drug and must be used under the supervision of an experienced physician.

Patients must not adjust the dosage or discontinue the drug on their own. Regular examinations of platelets, liver function, and renal function are required to ensure medication safety.

Confirm Medication Storage Conditions

The medication must be stored under refrigeration at 2°C–8°C.

After being removed from the refrigerator, it can be stored in its original packaging at room temperature (not exceeding 30°C) for a maximum of 6 weeks.

If this time limit is exceeded or the medication is improperly stored, it should be discarded.

Check the Integrity of Medication Packaging

Each prefilled syringe is for single use, and the packaging should include an outer box, the syringe, and its protective cap.

If the packaging is damaged, the needle cap is loose, or the liquid is turbid or contains particles, discontinue use immediately and contact the pharmacy or physician.

Understand Adverse Reactions and Reporting Mechanisms

Common adverse reactions of volanesorsen include injection site reactions, thrombocytopenia, and abnormalities in liver and renal function.

If patients experience symptoms such as abnormal bleeding, jaundice, or decreased urine output during treatment, they should seek medical attention immediately and report the adverse reactions.

How to Distinguish the Authenticity of Volanesorsen (Waylivra)?

Verify Medication Appearance and Label Information

Genuine volanesorsen is a colorless to pale yellow clear liquid. The prefilled syringe should clearly display the medication name, dosage (285mg/1.5ml), batch number, expiration date, and other information.

Any ambiguity in labeling, incomplete information, or inconsistency with official descriptions should arouse vigilance.

Inspect Packaging and Anti-Counterfeiting Features

European Union (EU) Marketing Authorization Number: EU/1/19/1360/001 or EU/1/19/1360/002.

Manufacturer Information: Almac Pharma Services Ireland Ltd.

Two-dimensional (2D) barcode and unique identification code.